FDA News

FDA: Fluoroquinolones increase odds of aortic dissection, AAA rupture

December 20, 2018
The FDA issued a safety alert stating that fluoroquinolone antibiotics increase the odds of aortic dissection and ruptures of aortic aneurysms. The…

Meeting News

DCBs confer similar patency in 1-year interim analysis

December 20, 2018
A drug-coated balloon with a low dose of paclitaxel showed similar patency to a standard-dose paclitaxel-eluting balloon, according to an interim…

In the Journals

Outpatient tibial endovascular procedures safe regardless of setting

December 18, 2018
Outpatient endovascular tibial artery interventions were equally safe in office-based and hospital settings, researchers reported. The researchers…

In the Journals

Report guides clinicians on revascularization options for PAD

December 17, 2018
Five societies released appropriate use criteria for interventions for peripheral artery disease. According to the report from the American College…

In the Journals

Kissing-stent technique effective in aortoiliac occlusive disease

December 10, 2018
According to a patient-level meta-analysis, the kissing-stent technique was safe and maintained acceptable patency rates at 2 years in patients with…

Meeting News

Resorbable large bore closure system safe, effective in first-in-human study

December 6, 2018
LAS VEGAS — Preliminary data from a first-in-human study show safety and effectiveness of a resorbable vascular sealing system for large bore…

Meeting News

Vascular intervention highlights from VIVA 18

December 5, 2018
This year at VIVA 18, the focus was on new advances for vascular intervention. Cardiology Today’s Intervention was onsite at VIVA 18 in Las…

In the Journals

Risk for revascularization, MACE elevated with polyvascular disease

December 4, 2018
Compared with patients with peripheral artery disease alone, patients with PAD plus disease in other vascular beds had elevated risk for…

Top intervention news of November

December 3, 2018
Cardiology Today’s Intervention compiled a list of the most popular articles posted to Healio.com/Intervention in November. This month, our…

In the Journals

DISRUPT PAD II: Intravascular lithotripsy linked to minimal vessel injury in stenotic peripheral arteries

November 30, 2018
Patients with complex calcified peripheral artery stenosis who underwent intravascular lithotripsy had minimal vessel injury and minimal use of…

Meeting News

Peripheral stent confers good outcomes in CFA disease

November 29, 2018
LAS VEGAS — A peripheral stent was safe and effective for treatment of common femoral artery lesions at 12 months, according to data presented…

Meeting News

Catheter-based delivery of paclitaxel beneficial in PAD

November 28, 2018
LAS VEGAS — The use of a catheter to deliver paclitaxel to prevent restenosis in patients with below-the-knee lesions was safe and effective…

Meeting News

Laser atherectomy system safe, effective in first-in-humans study

November 27, 2018
LAS VEGAS — A laser atherectomy system for treatment of peripheral artery lesions was safe and effective in a first-in-humans study…

In the Journals

Boston Scientific reaches agreement to acquire BTG

November 20, 2018
Boston Scientific announced it has reached an agreement regarding a recommended offer to acquire BTG plc, which develops and makes products to treat…

The Take Home

The Take Home: SVS

Cardiology Today's Intervention, November/December 2018
Vascular surgeons, interventional cardiologists, interventional radiologists and a wide variety of other health care professionals turned out for the…

Innovation Spotlight

Innovation Spotlight

Cardiology Today's Intervention, November/December 2018
Advanced Bifurcation Systems announced that it has filed a pre-submission with the FDA to define its clinical pathway leading to a PMA for its new…

PAD in Focus

Aortoiliac Occlusive Disease: Open vs. Endovascular Approach

Cardiology Today's Intervention, November/December 2018
Jessica M. Titus, MD
The manifestation of peripheral vascular disease in the aortoiliac segment is common, and thus its management is a frequent part of the day-to-day…

Meeting News

STOP-PAD: Biologic therapy for CLI remains ineffective at 6 months

November 19, 2018
LAS VEGAS — An experimental biologic treatment did not improve wound healing or clinical outcomes in patients with critical limb ischemia…

Meeting News

Novel DCB improves Rutherford class, other outcomes at 1 year

November 14, 2018
LAS VEGAS — A novel drug-coated balloon conferred improvement in Rutherford class, ankle-brachial index and several measures of walking ability…

Meeting News

First US patient enrolled in below-the-knee trial for DCB

November 13, 2018
Philips announced that the first U.S. patient has been enrolled in the investigational device exemption trial of its drug-coated balloon designed to…